Lacarrubba Francesco, Verzì Anna Elisa, Dimarco Stefano, Luppino Ivano, dall'Oglio Federica, Micali Giuseppe
Clinica Dermatologica, Università di Catania.
Recenti Prog Med. 2024 Oct;115(10):37e-41e. doi: 10.1701/4357.43475.
A 72-year-old man presented with actinic keratosis (AK) of the scalp confirmed by line-field confocal optical coherence tomography (LC-OCT) a novel non-invasive skin imaging technique. Patient was treated with Tirbanibulin 1% ointment once a day for 5 consecutive days and, after 8 days from baseline, mild erythema and desquamation was observed on the treated area, associated with mild pruritus. At the same time-point, L'LC-OCT revealed the presence of intraepidermal "targeted-like" cells, corresponding to apoptotic keratinocytes. After 2 months, clinical and instrumental examination showed the almost total disappearance of the AK. At the same time-point, a strong improvement of photoaging was noted at the level of the treated area. At 1-year follow-up, no relapse and/or new AK were observed. In conclusion, the reported case is emblematic of the short and long-term efficacy and safety of tirbanibulin in the treatment of AK, as already reported in the literature, as well as of the usefulness of non-invasive imaging technique such as LC-OCT in the therapeutic monitoring.
一名72岁男性因头皮光化性角化病(AK)就诊,经线场共聚焦光学相干断层扫描(LC-OCT,一种新型非侵入性皮肤成像技术)确诊。患者接受1%替巴替尼软膏治疗,每天一次,连续5天,从基线起8天后,治疗区域出现轻度红斑和脱屑,并伴有轻度瘙痒。在同一时间点,LC-OCT显示存在表皮内“靶向样”细胞,对应凋亡的角质形成细胞。2个月后,临床和仪器检查显示AK几乎完全消失。在同一时间点,观察到治疗区域的光老化有明显改善。在1年随访中,未观察到复发和/或新的AK。总之,如文献中已报道的那样,该病例体现了替巴替尼治疗AK的短期和长期疗效及安全性,以及诸如LC-OCT等非侵入性成像技术在治疗监测中的有用性。